ChemImpex Zonisamide; 98% (HPLC); 68291-97-4; MFCD00865316, 1G

Name: ChemImpex Zonisamide; 98% (HPLC); 68291-97-4; MFCD00865316, 1G
SKU: CMX-38370-1G
Price: 455.87 USD

List Price $455.87 Your Price $455.87

ChemImpex Zonisamide; 98% (HPLC); 68291-97-4; MFCD00865316 - CMX (Additional S&H or Hazmat Fees May Apply)

NETA PART: CMX-38370-1G

MFG.PART: 38370-1G

UNSPSC: 12350000

Manufacturer: Chem Impex International

Skip to the end of the images gallery

Skip to the beginning of the images gallery

Description

Zonisamide is a versatile sulfonamide compound recognized for its efficacy in the treatment of epilepsy and other neurological disorders. This compound exhibits a unique mechanism of action, which includes the inhibition of voltage-gated sodium channels and the modulation of neurotransmitter release, making it a valuable option for managing seizure disorders. Its ability to cross the blood-brain barrier allows for effective therapeutic concentrations in the central nervous system, providing significant benefits for patients with refractory epilepsy.

In addition to its primary use in neurology, Zonisamide has shown potential in weight management and the treatment of mood disorders, expanding its relevance in various therapeutic areas. Researchers and healthcare professionals appreciate its favorable side effect profile compared to other antiepileptic drugs, making it a preferred choice in polytherapy settings. With ongoing studies exploring its broader applications, Zonisamide stands out as a promising compound in both clinical and research environments.

Specifications

Synonyms	1,2-Benzisoxazole-3-methanesulfonamide
CAS Number	68291-97-4
Purity	≥ 98% (HPLC)
Molecular Formula	C₈H₈N₂O₃S
Molecular Weight	212.22
MDL Number	MFCD00865316
PubChem ID	5734
Melting Point	163 - 167 °C
Appearance	White to almost white powder to crystal
Conditions	Store at 2 - 8 °C

Safety & Regulations

Hazmat	No
Antibiotic	No
DEA-regulated	No
Warnings	-

Zonisamide is widely utilized in research focused on:

Epilepsy Treatment: Commonly prescribed as an anticonvulsant, it helps manage seizures in patients with epilepsy, offering a valuable alternative for those who do not respond to other medications.
Weight Management: Research indicates its potential in weight loss therapies, as it may help reduce appetite and promote metabolic changes, making it beneficial for obesity treatment.
Parkinsons Disease: Studies suggest that it may have neuroprotective effects, providing a supplementary treatment option for patients suffering from Parkinsons disease.
Chronic Pain Management: Zonisamide is being explored for its analgesic properties, offering potential relief for patients with chronic pain conditions, enhancing their quality of life.
Research in Neurodegenerative Disorders: Its unique mechanism of action is being investigated for broader applications in neurodegenerative diseases, potentially leading to new therapeutic strategies.

Specifications

More Information
SKU	CMX-38370-1G
Supplier Part Number	38370-1G
UM	EA
UNSPSC	12350000
Manufacturer	Chem Impex International
Temperature	Store at 2 - 8 °C
ProductLine	CMX
Qty	1
MinOrderQty	1
Weight	7.000000
Lead Time	5
Hazardous	N
CAS Number	68291-97-4
Energy Star	No
Green	No
Controlled	N

Provide Content Correction

NETA PART NO.	Quantity

ChemImpex Zonisamide; 98% (HPLC); 68291-97-4; MFCD00865316, 1G

Specifications

Safety & Regulations

Product Title